PIR and renal cell adenocarcinoma: To further confirm whether piR-1742 acts independently as a prognostic indicator in RCC patients, we performed ROC curve analysis and found that the expression of piR-1742 was differed markedly between RCC and normal tissues, with an AUC of 0.842.